Wedbush Morgan initiates coverage on Momenta Pharmaceuticals (Nasdaq: MNTA) with a Buy.

Wedbush analyst says, "We believe that Momenta Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE